Company Overview of Biosyn, Inc.
As of October 22, 2004, Biosyn, Inc. was acquired by Cellegy Pharmaceuticals Inc. Biosyn, Inc. is a pharmaceutical company that develops drugs for infectious disease and reproductive health. The company offers products for contraception and sexually transmitted diseases (STDs); oral infections associated with immune-suppression; and skin and soft tissue infections (SSTIs) including acne and impetigo. Its products include C31G Vaginal Gel, C31G Oral Rinse, C31G Dermal, UC-781, and Cyanovirin-N (CV-N). Biosyn was founded in 1989 and is based in Huntingdon Valley, Pennsylvania.
1800 Byberry Road
Huntingdon Valley, PA 19006-3525
Founded in 1989
Key Executives for Biosyn, Inc.
Biosyn, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Biosyn, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.